Fluid Biomed Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $27M

  • Investors
  • 23

Fluid Biomed General Information

Description

Developer of polymer-based medical devices intended to commercialize the next generation of stents to heal blood vessels. The company's device is a revolutionary implantable bio-absorbable polymer-based flow-diverting stent designed to gently divert blood flow to heal a weakened brain aneurysm, enabling physicians to efficiently and quickly treat patients and prevent stroke.

Contact Information

Formerly Known As
Fluid Biotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3655 - 36 Street North West
  • Calgary, Alberta T2L 1Y8
  • Canada
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Corporate Office
  • 3655 - 36 Street North West
  • Calgary, Alberta T2L 1Y8
  • Canada

Fluid Biomed Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluid Biomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 16-Nov-2024 $27M Completed Clinical Trials - General
7. Accelerator/Incubator Completed Clinical Trials - General
6. Accelerator/Incubator 07-Jun-2022 Completed Clinical Trials - General
5. Seed Round 01-Jul-2021 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Apr-2020 Completed Pre-Clinical Trials
3. Seed Round 31-Dec-2019 Completed Pre-Clinical Trials
2. Grant 07-Jun-2019 $74.3K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Fluid Biomed’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Fluid Biomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fluid Biomed Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accelerate Fund Venture Capital Minority
Adara Venture Capital Venture Capital Minority
Amplitude Ventures Venture Capital Minority
IAG Capital Partners Venture Capital Minority
LifeArc Ventures Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Fluid Biomed FAQs

  • When was Fluid Biomed founded?

    Fluid Biomed was founded in 2012.

  • Where is Fluid Biomed headquartered?

    Fluid Biomed is headquartered in Calgary, Canada.

  • What is the size of Fluid Biomed?

    Fluid Biomed has 13 total employees.

  • What industry is Fluid Biomed in?

    Fluid Biomed’s primary industry is Therapeutic Devices.

  • Is Fluid Biomed a private or public company?

    Fluid Biomed is a Private company.

  • What is Fluid Biomed’s current revenue?

    The current revenue for Fluid Biomed is .

  • How much funding has Fluid Biomed raised over time?

    Fluid Biomed has raised $32.6M.

  • Who are Fluid Biomed’s investors?

    Accelerate Fund, Adara Venture Capital, Amplitude Ventures, IAG Capital Partners, and LifeArc Ventures are 5 of 23 investors who have invested in Fluid Biomed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »